机译:遗嘱及其基于稀有疾病的药物的方法:具有生长激素缺乏的成人的人体生长激素替代的故事
Sydney Health EthicsUniversity of SydneySydney New South Wales Australia;
Department of Endocrinology and DiabetesSydney Children's Hospital Network‐WestmeadSydney New South;
Southern Adelaide Diabetes and Endocrine Services Flinders Medical CentreFlinders;
Department of Endocrinology and DiabetesWomen's and Children's HospitalAdelaide South Australia;
Department of Diabetes and EndocrinologyPrincess Alexandra HospitalBrisbane Queensland Australia;
Department of Endocrinology and DiabetesRoyal Children's HospitalVictoria Australia;
Department of Diabetes and EndocrinologyPrincess Alexandra HospitalBrisbane Queensland Australia;
growth hormone; pharmaceutical benefits scheme; rare disease; clinical advocacy; public interest submission;
机译:遗嘱及其基于稀有疾病的药物的方法:具有生长激素缺乏的成人的人体生长激素替代的故事
机译:生长激素替代疗法是否会降低患有生长激素缺乏症的成年人的死亡率?荷兰成人生长激素治疗国家注册局的数据
机译:生长激素替代疗法是否会降低患有生长激素缺乏症的成年人的死亡率?荷兰成人生长激素治疗国家注册局的数据
机译:有和没有荷尔蒙缺乏症的儿童生长激素分泌型态的比较
机译:更高的期望:美国人类生长激素行业的历史。
机译:长期生长激素替代治疗对成人生长激素缺乏的代谢和心血管参数的影响:成人和老年患者的比较
机译:生长激素替代疗法是否可以降低患有生长激素缺乏症的成年人的死亡率?荷兰成人生长激素治疗国家注册数据